Leading the pharmacogenetics market Align with the guidelines CYP2C19 genotyping to guide dual antiplatelet therapy decision making, is now included in the new AHA/ASA guideline for Early Management of Patients with Acute Ischemic Stroke New AHA/ASA Guideline Same Treatment Different People Different Results Every person, including you, carries genetic variations that influence how your body […]